While there’s been plenty of debate about the tendency of AI chatbots to flatter users and confirm their existing beliefs — also known as AI sycophancy — a new study by Stanford computer scientists ...

Share on Pinterest Almost half of the people who stop GLP-1 drugs may be able to prevent weight regain, a new study suggests. Image credit: FreshSplash/Getty Images A real-world study followed ...

Four new tax deductions are available on federal returns for eligible taxpayers whether they itemize deductions, such as claiming mortgage interest, or claim the standard deduction. All four big tax ...

A new tax form, Schedule 1-A, must be filed with 2025 returns to claim several new deductions. These new tax breaks include deductions for qualified tip income, overtime pay, and new car loan interest ...

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems. However, if people stop taking the medication, those heart ...

Fat, not skeletal muscle, accounted for most of the weight loss. According to the study, GLP-1 medicines reduced body fat in obese mice much more than lean body mass, and fat and liver mass fell ...

A newly published academic study is shedding light on nihilistic violent extremism. The research, published in Taylor & Francis Online by Mackenzie B. Hart, analyzes long-form manifestos written by ...

The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints — stomachaches, constipation — generally unpleasant but tolerable ...

GLP-1 medications such as Ozempic and Wegovy have transformed treatment for Type 2 diabetes and obesity, but new research suggests doctors may need to pay closer attention to bone health, especially ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

GLP-1 drugs reduced substance use disorders in patients with type 2 diabetes. GLP-1 users had lower odds of new disorders or adverse outcomes of existing disorders. Effect was seen across broad range ...

A little brain training today may help stave off Alzheimer's disease and other forms of dementia for at least 20 years. That's the conclusion of a study of older adults who participated in a cognitive ...